Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234494
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2005-10-05
Brief Title:
Cisplatin Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
Sponsor:
Christopher Sweeney MBBS
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HOG GU04-75
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Christopher Sweeney MBBS
Lead Sponsor Class:
OTHER
Responsible Party:
Christopher Sweeney MBBS
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoosier Cancer Research Network | OTHER |
| Genentech Inc | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |
| Walther Cancer Institute | OTHER |